Pages

Tuesday, March 21, 2017

GAO To Launch Investigation Of FDA's Orphan Drug Program

Kaiser Health News-6 hours ago
That's in part because of the exorbitant prices that can be charged. Of the top 100 drugs in the U.S., the average cost per patient per year for an orphan drug was 
Post a Comment